ARCHIVES

Scientists, Public Citizen Urge FDA To Ban Sale Of Obesity Drug Orlistat.

This article is from The Cancer Letter archive.

Vol. 32 No. 21 | June 2, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

Sloan-Kettering Sues Empire Blue Cross Over Reimbursement

September 17, 1993

New NCI Director Proposes $9 Million Community Cancer Centers Program.

September 8, 2006

Pesticides Not A Risk Factor For Long Island Breast Cancer, Study Finds

September 6, 2002

NCI Advisors Approve Research Network On Screening

August 6, 2010

Targeted Biopsy More Effective At Selecting Men For Active Surveillance, Study Says

May 30, 2014